Vmn2r76 Inhibitors
Vmn2r76 can operate through various biochemical pathways to impede its function. Phentolamine and Yohimbine, as alpha-adrenergic antagonists, can block the alpha-adrenergic receptors that are involved in Vmn2r76's signaling processes, leading to decreased receptor activity. Similarly, Propranolol, Labetalol, and Carvedilol, which have beta-adrenergic receptor-blocking capabilities in addition to alpha receptor antagonism in the case of the latter two, can interfere with the beta-adrenergic pathways that can be integral to the functioning of Vmn2r76. These chemicals can prevent the normal agonist-induced activation of these receptors, thereby inhibiting the expected physiological responses.
Losartan and Telmisartan can obstruct the action of angiotensin II receptors. By doing so, they can alter the signaling cascades that can influence the activity of Vmn2r76. Calcium channel blockers such as Nicardipine, Verapamil, Nifedipine, Diltiazem, and Amlodipine can restrict calcium influx into cells, which can be essential for the activation and function of Vmn2r76. By diminishing intracellular calcium levels, these inhibitors can alter the cellular signaling environment and impede the functional activity of Vmn2r76. Each of these agents can act on different receptors or channels that can be linked to the pathways in which Vmn2r76 is implicated, leading to a reduction in its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a beta-adrenergic antagonist that could hinder the signaling cascade in which Vmn2r76 may participate, by blocking beta-adrenergic receptors and inhibiting the downstream signaling that might contribute to Vmn2r76's functional activation. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine acts as an alpha-2 adrenergic receptor antagonist. By inhibiting these receptors, it could disrupt the signaling pathways that Vmn2r76 is involved in, effectively reducing Vmn2r76's ability to engage in its normal physiological processes. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan, an angiotensin II receptor antagonist, could disrupt signaling pathways that may intersect with or regulate Vmn2r76 activity, thus indirectly inhibiting Vmn2r76 by preventing angiotensin II from exerting its effects on blood pressure and electrolyte balance. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Telmisartan is another angiotensin II receptor blocker that might inhibit signaling pathways that Vmn2r76 relies on for proper function, thereby indirectly reducing the activity of Vmn2r76 by blocking the effects of angiotensin II. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is another calcium channel blocker that could decrease intracellular calcium, which might be necessary for Vmn2r76 signaling or activity, thereby leading to an indirect functional inhibition of Vmn2r76. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, as a calcium channel blocker, could lower calcium levels within cells and thus may indirectly inhibit Vmn2r76 by altering the cellular environment and signaling pathways that Vmn2r76 depends on for activation. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem, by blocking calcium channels, could modulate the intracellular calcium concentration which is potentially important for Vmn2r76 function, leading to an indirect inhibition of Vmn2r76 activity. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Amlodipine is a calcium channel blocker that could indirectly inhibit Vmn2r76 by preventing calcium influx, thus affecting the intracellular signaling that Vmn2r76 might be involved in, resulting in decreased Vmn2r76 activity. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Labetalol acts as both an alpha and beta adrenergic receptor antagonist. This dual action could lead to an inhibition of adrenergic pathway signaling, potentially impeding the signaling mechanisms that Vmn2r76 may be a part of and thus indirectly inhibiting Vmn2r76 function. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Carvedilol is a non-selective beta-blocker and alpha-1 blocker that could inhibit signaling pathways involving adrenergic receptors, pathways which Vmn2r76 might be associated with, leading to an indirect inhibition of Vmn2r76 function. | ||||||